NDC00300-3626-30: LEUPROLIDE ACETATE INJECTION KIT.
LEUPROLIDE ACETATE INJECTION KIT. Key specifications include usage_design: USED IN TREATMENT OF PROSTATIC CANCER, test_capability_quantity: 28, protective_storage_feature: ANTINEOPLASTIC DRUG AND REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS AND SUBJECT TO DAMAGE BY FREEZING, part_name_assigned_by_controlling_agency: LEUPROLIDE ACETATE INJECTION KIT 2.8ML MULTI DOSE VIAL 4 WEEK KIT. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-252-0045, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| usage_design | USED IN TREATMENT OF PROSTATIC CANCER |
| test_capability_quantity | 28 |
| protective_storage_feature | ANTINEOPLASTIC DRUG AND REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS AND SUBJECT TO DAMAGE BY FREEZING |
| part_name_assigned_by_controlling_agency | LEUPROLIDE ACETATE INJECTION KIT 2.8ML MULTI DOSE VIAL 4 WEEK KIT |
| NSN | 6505-01-252-0045 |
| SPECIAL FEATURES | STERILE,AQUEOUS SOLUTION FOR SUBCUTANEOUS INJECTION; 2.8ML MULTI-DOSE VIAL (5MG LEUPROLIDE ACETATE PER ML) 1; 1ML DISPOSABLE SYRINGE WITH 27 GAGE 1/2 IN. NEEDLE 18; INDIVIDUALLY FOIL WRAPPED ALCOHOL WIPES 56 IN |
| PROTECTIVE STORAGE FEATURE | ANTINEOPLASTIC DRUG AND REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS AND SUBJECT TO DAMAGE BY FREEZING |
| TEST CAPABILITY QUANTITY | 28 |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | LEUPROLIDE ACETATE INJECTION KIT 2.8ML MULTI DOSE VIAL 4 WEEK KIT |
| USAGE DESIGN | USED IN TREATMENT OF PROSTATIC CANCER |